APRN Week 2021



Download Poster (723 KB)


  • The implementation of IDS tool, which is integrated in the Epic, can assist providers in placing appropriate BBI insulin orders.
  • Increased use of BBI use can result in reduction in hyperglycemia and hypoglycemia which can enhances overall patient safety and outcomes.
  • Expanding or standardizing the intervention to other areas can help change prescriber practice and better glycemic control.
  • Provider involvement and interest is an important factor in the utilization of the IDS tool.

Sigi Varghese pictured.

Publication Date


Meeting Inpatient Glycemic Targets through Increased use of  Basal Bolus Insulin Therapy



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.